These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 16817957)
21. Venous thromboembolism and anticoagulant therapy in pregnancy. Greer IA Gend Med; 2005; 2 Suppl A():S10-7. PubMed ID: 16551552 [TBL] [Abstract][Full Text] [Related]
22. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
23. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634 [TBL] [Abstract][Full Text] [Related]
24. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis. Chapman TM; Goa KL Drugs; 2003; 63(21):2357-77. PubMed ID: 14524738 [TBL] [Abstract][Full Text] [Related]
25. Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patients. Pineo GF; Hull RD Clin Appl Thromb Hemost; 2009 Oct; 15(5):489-500. PubMed ID: 19520676 [TBL] [Abstract][Full Text] [Related]
26. The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients. Pineo GF; Lin J; Annemans L Clinicoecon Outcomes Res; 2012; 4():99-107. PubMed ID: 22570556 [TBL] [Abstract][Full Text] [Related]
27. Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders. Dunn CJ; Sorkin EM Drugs; 1996 Aug; 52(2):276-305. PubMed ID: 8841743 [TBL] [Abstract][Full Text] [Related]
28. Enoxaparin once daily vs. twice daily dosing for the treatment of venous thromboembolism in cancer patients: a literature summary. Diaz AH; Rodgers GM; Gilreath JA J Oncol Pharm Pract; 2012 Jun; 18(2):264-70. PubMed ID: 21930652 [TBL] [Abstract][Full Text] [Related]
29. Comparison of injectable anticoagulants for thromboprophylaxis after cancer-related surgery. Changolkar A; Menditto L; Shah M; Puto K; Farrelly E Am J Health Syst Pharm; 2014 Apr; 71(7):562-9. PubMed ID: 24644116 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure. Amin AN; Kartashov A; Ngai W; Steele K; Rosenthal N J Health Econ Outcomes Res; 2024; 11(1):44-56. PubMed ID: 38390025 [No Abstract] [Full Text] [Related]
31. Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial. Pai M; Adhikari NKJ; Ostermann M; Heels-Ansdell D; Douketis JD; Skrobik Y; Qushmaq I; Meade M; Guyatt G; Geerts W; Walsh MW; Crowther MA; Friedrich JO; Burry L; Bellomo R; Brandão da Silva N; Costa Filho R; Cox MJ; Alves Silva S; Cook DJ; PLoS One; 2018; 13(6):e0198285. PubMed ID: 29856817 [TBL] [Abstract][Full Text] [Related]
32. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients. Rothberg MB; Pekow PS; Lahti M; Lindenauer PK J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716 [TBL] [Abstract][Full Text] [Related]
33. New versus established drugs in venous thromboprophylaxis: efficacy and safety considerations related to timing of administration. Tribout B; Colin-Mercier F Am J Cardiovasc Drugs; 2007; 7(1):1-15. PubMed ID: 17355162 [TBL] [Abstract][Full Text] [Related]
34. Review of enoxaparin and its clinical applications in venous and arterial thromboembolism. Turpie AG; Mason JA Expert Opin Pharmacother; 2002 May; 3(5):575-98. PubMed ID: 11996636 [TBL] [Abstract][Full Text] [Related]
35. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360 [TBL] [Abstract][Full Text] [Related]
36. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Apr; (4):CD006649. PubMed ID: 21491395 [TBL] [Abstract][Full Text] [Related]